Physician profile
Ashwini Reddy
NPI 1982673000
$8,303.80
in general payments reported to CMS, 2019-2025
47 companies · $1,543 in 2025
The $1,543 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,114 · 2020: $796 · 2021: $1,001 · 2022: $963 · 2023: $1,029 · 2024: $1,858 · 2025: $1,543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,430.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,285.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $756.86 | 2019-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $680.67 | 2019-2025 | |
| Lilly USA, LLC | $652.85 | 2019-2024 | Mounjaro, Humulin, Zepbound |
| Amarin Pharma, INC. | $606.17 | 2019-2022 | |
| Medtronic, INC. | $371.61 | 2021-2025 | Minimed 780g |
| Dexcom, INC. | $334.11 | 2019-2025 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $305.95 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Radius Health, INC. | $297.91 | 2019-2025 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $291.42 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $284.68 | 2019-2022 | |
| Beta Bionics, INC. | $251.04 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.75 | 2020-2025 | Jardiance |
| Abbvie INC. | $209.07 | 2020-2025 | |
| Insulet Corporation | $183.78 | 2022-2024 | Omnipod |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashwini Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.